Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction

References

• Garewal HS. (1988) Mitomycin C in the chemotherapy of advanced breast cancer, Semin Oncol 15:74-9; PMID:3134698
   PubMed Web of Science ®Google Scholar
• Bradner WT. (2001) Mitomycin C: a clinical update, Cancer Treat Rev 27:35-50; PMID:11237776; http://dx.doi.org/10.1053/ctrv.2000.0202
   PubMed Web of Science ®Google Scholar
• Bargonetti J, Champeil E, and Tomasz M. (2010) Differential toxicity of DNA adducts of mitomycin C, J Nucleic Acids 2010; PMID:20798760; http://dx.doi.org/10.4061/2010/698960
   PubMedGoogle Scholar
• Lawley PD, Phillips DH. (1996) DNA adducts from chemotherapeutic agents, Mutat Res 355:13-40; PMID:8781575; http://dx.doi.org/10.1016/0027-5107(96)00020-6
   PubMed Web of Science ®Google Scholar
• Boamah EK, Brekman A, Tomasz M, Myeku N, Figueiredo-Pereira M, Hunter S, Meyer J, Bhosle RC, Bargonetti J. (2010) DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1, Chem Res Toxicol 23:1151-62; PMID:20536192; http://dx.doi.org/10.1021/tx900420k
   PubMed Web of Science ®Google Scholar
• Boamah EK, White DE, Talbott KE, Arva NC, Berman D, Tomasz M, Bargonetti J. (2007) Mitomycin-DNA adducts induce p53-dependent and p53-independent cell death pathways, ACS Chem Biol 2:399-407; PMID:17530733; http://dx.doi.org/10.1021/cb700060t
   PubMed Web of Science ®Google Scholar
• Abbas T, Olivier M, Lopez J, Houser S, Xiao G, Kumar GS, Tomasz M, Bargonetti J. (2002) Differential activation of p53 by the various adducts of mitomycin C, J Biol Chem 277:40513-9; PMID:12183457; http://dx.doi.org/10.1074/jbc.M205495200
   PubMed Web of Science ®Google Scholar
• Hussain SP, Harris CC. (1998) Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes, Cancer Res 58:4023-37; PMID:9751603
   PubMed Web of Science ®Google Scholar
• (2012) Comprehensive molecular portraits of human breast tumours, Nature 490:61-70; PMID:23000897; http://dx.doi.org/10.1038/nature11412
   PubMed Web of Science ®Google Scholar
• Reaper PM, Griffiths MR, Long JM, Charrier JD, Maccormick S, Charlton PA, Golec JM, Pollard JR. (2011) Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR, Nat Chem Biol 7:428-30; PMID:21490603; http://dx.doi.org/10.1038/nchembio.573
   PubMed Web of Science ®Google Scholar
• Xie L, Gazin C, Park SM, Zhu LJ, Debily MA, Kittler EL, Zapp ML, Lapointe D, Gobeil S, Virbasius CM, et al. (2012) A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells, PLoS Genet 8:e1003151; PMID:23284306; http://dx.doi.org/10.1371/journal.pgen.1003151
   PubMedGoogle Scholar
• Deans AJ, West SC. (2011) DNA interstrand crosslink repair and cancer, Nat Rev Cancer 11:467-80; PMID:21701511; http://dx.doi.org/10.1038/nrc3088
   PubMed Web of Science ®Google Scholar
• O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA. (2003) A splicing mutation affecting expression of ataxia-telangiectasia and rad3-related protein (ATR) results in seckel syndrome, Nat Genet 33:497-501; PMID:12640452; http://dx.doi.org/10.1038/ng1129
   PubMed Web of Science ®Google Scholar
• Brown EJ, Baltimore D. (2000) ATR disruption leads to chromosomal fragmentation and early embryonic lethality, Genes Dev 14:397-402; PMID:10691732
   PubMed Web of Science ®Google Scholar
• Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, Abraham RT. (2000) Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress, Genes Dev 14:2989-3002; PMID:11114888; http://dx.doi.org/10.1101/gad.851000
   PubMed Web of Science ®Google Scholar
• Brown AD, Sager BW, Gorthi A, Tonapi SS, Brown EJ, Bishop AJ. (2014) ATR suppresses endogenous DNA damage and allows completion of homologous recombination repair, PLoS One 9:e91222; PMID:24675793; http://dx.doi.org/10.1371/journal.pone.0091222
   PubMedGoogle Scholar
• Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB. (2007) p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage, Cancer Cell 11:175-89; PMID:17292828; http://dx.doi.org/10.1016/j.ccr.2006.11.024
   PubMed Web of Science ®Google Scholar
• Reinhardt HC, Hasskamp P, Schmedding I, Morandell S, van Vugt MA, Wang X, Linding R, Ong SE, Weaver D, Carr SA, et al. (2010) DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization, Mol Cell 40:34-49; PMID:20932473; http://dx.doi.org/10.1016/j.molcel.2010.09.018
   PubMed Web of Science ®Google Scholar
• Tamura RE, de Vasconcellos JF, Sarkar D, Libermann TA, Fisher PB, Zerbini LF. (2012) GADD45 proteins: central players in tumorigenesis, Curr Mol Med 12:634-51; PMID:22515981; http://dx.doi.org/10.2174/156652412800619978
   PubMed Web of Science ®Google Scholar
• Zhao H, Piwnica-Worms H. (2001) ATR-mediated checkpoint pathways regulate phosphorylation and activation of human chk1, Mol Cell Biol 21:4129-39; PMID:11390642; http://dx.doi.org/10.1128/MCB.21.13.4129-4139.2001
   PubMed Web of Science ®Google Scholar
• Zou L, Elledge SJ. (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes, Science 300:1542-8; PMID:12791985; http://dx.doi.org/10.1126/science.1083430
   PubMed Web of Science ®Google Scholar
• Pabla N, Ma Z, McIlhatton MA, Fishel R, Dong Z. (2011) hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis, J Biol Chem 286:10411-8; PMID:21285353; http://dx.doi.org/10.1074/jbc.M110.210989
   PubMed Web of Science ®Google Scholar
• Toledo LI, Altmeyer M, Rask MB, Lukas C, Larsen DH, Povlsen LK, Bekker-Jensen S, Mailand N, Bartek J, Lukas J. (2013) ATR prohibits replication catastrophe by preventing global exhaustion of RPA, Cell 155:1088-103; PMID:24267891; http://dx.doi.org/10.1016/j.cell.2013.10.043
   PubMed Web of Science ®Google Scholar
• Sirbu BM, Couch FB, Feigerle JT, Bhaskara S, Hiebert SW, Cortez D. (2011) Analysis of protein dynamics at active, stalled, and collapsed replication forks, Genes Dev 25:1320-7; PMID:21685366; http://dx.doi.org/10.1101/gad.2053211
   PubMed Web of Science ®Google Scholar
• Polo SE, Jackson SP. (2011) Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications, Genes Dev 25, 409-33; PMID:21363960; http://dx.doi.org/10.1101/gad.2021311
   PubMed Web of Science ®Google Scholar
• Stone HR, Morris JR. (2014) DNA damage emergency: cellular garbage disposal to the rescue?, Oncogene 33:805-13; PMID:23503465; http://dx.doi.org/10.1038/onc.2013.60
   PubMed Web of Science ®Google Scholar
• Raderschall E, Golub EI, Haaf T. (1999) Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage, Proc Natl Acad Sci U S A 96:1921-6; PMID:10051570; http://dx.doi.org/10.1073/pnas.96.5.1921
   PubMed Web of Science ®Google Scholar
• Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM. (2003) p53 has a direct apoptogenic role at the mitochondria, Mol Cell 11:577-90; PMID:12667443; http://dx.doi.org/10.1016/S1097-2765(03)00050-9
   PubMed Web of Science ®Google Scholar
• Dart DA, Adams KE, Akerman I, Lakin ND. (2004) Recruitment of the cell cycle checkpoint kinase ATR to chromatin during S-phase, J Biol Chem 279:16433-40; PMID:14871897; http://dx.doi.org/10.1074/jbc.M314212200
   PubMed Web of Science ®Google Scholar
• Jiang G, Sancar A. (2006) Recruitment of DNA damage checkpoint proteins to damage in transcribed and nontranscribed sequences, Mol Cell Biol 26:39-49; PMID:16354678; http://dx.doi.org/10.1128/MCB.26.1.39-49.2006
   PubMed Web of Science ®Google Scholar
• Brekman A, Singh KE, Polotskaia A, Kundu N, Bargonetti J. (2011) A p53-independent role of mdm2 in estrogen-mediated activation of breast cancer cell proliferation, Breast Cancer Res 13:R3; PMID:21223569; http://dx.doi.org/10.1186/bcr2804
   PubMedGoogle Scholar
• Pang B, Qiao X, Janssen L, Velds A, Groothuis T, Kerkhoven R, Nieuwland M, Ovaa H, Rottenberg S, van Tellingen O, et al. (2013) Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin, Nat Commun 4:1908; PMID:23715267; http://dx.doi.org/10.1038/ncomms2921
   PubMed Web of Science ®Google Scholar
• Liu S, Shiotani B, Lahiri M, Marechal A, Tse A, Leung CC, Glover JN, Yang XH, Zou L. (2011) ATR autophosphorylation as a molecular switch for checkpoint activation, Mol Cell 43:192-202; PMID:21777809; http://dx.doi.org/10.1016/j.molcel.2011.06.019
   PubMed Web of Science ®Google Scholar
• Sorensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, Bartek J, Helleday T. (2005) The cell-cycle checkpoint kinase chk1 is required for mammalian homologous recombination repair, Nat Cell Biol 7:195-201; PMID:15665856; http://dx.doi.org/10.1038/ncb1212
   PubMed Web of Science ®Google Scholar
• Krejci L, Altmannova V, Spirek M, Zhao X. (2012) Homologous recombination and its regulation, Nucleic Acids Res 40:5795-818; PMID:22467216; http://dx.doi.org/10.1093/nar/gks270
   PubMed Web of Science ®Google Scholar
• Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace AJ Jr., Zhan Q. (2000) BRCA1 activation of the GADD45 promoter, Oncogene 19:4050-7; PMID:10962562; http://dx.doi.org/10.1038/sj.onc.1203759
   PubMed Web of Science ®Google Scholar
• Reinhardt HC, Cannell IG, Morandell S, Yaffe MB. (2011) Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA damage response?, Cell Cycle 10:23-7; PMID:21173571; http://dx.doi.org/10.4161/cc.10.1.14351
   PubMed Web of Science ®Google Scholar
• Shanbhag NM, Rafalska-Metcalf IU, Balane-Bolivar C, Janicki SM, Greenberg RA. (2010) ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks, Cell 141:970-81; PMID:20550933; http://dx.doi.org/10.1016/j.cell.2010.04.038
   PubMed Web of Science ®Google Scholar
• Helleday T. (2003) Pathways for mitotic homologous recombination in mammalian cells, Mutat Res 532:103-15; PMID:14643432; http://dx.doi.org/10.1016/j.mrfmmm.2003.08.013
   PubMed Web of Science ®Google Scholar
• Canaani D. (2013) Application of the concept synthetic lethality toward anticancer therapy: a promise fulfilled?, Cancer Lett 352(1):59-65; PMID:23962561; http://dx.doi.org/10.1016/j.canlet.2013.08.019
   PubMed Web of Science ®Google Scholar
• Hall AB, Newsome D, Wang Y, Boucher DM, Eustace B, Gu Y, Hare B, Johnson MA, Milton S, Murphy CE. et al. (2014) Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970, Oncotarget 5:5674-85; PMID:25010037
   PubMed Web of Science ®Google Scholar
• Martino-Echarri E, Henderson BR, Brocardo MG. (2014) Targeting the DNA replication checkpoint by pharmacologic inhibition of chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy, Oncotarget 5:9889-900; PMID:25301724
   PubMed Web of Science ®Google Scholar
• Kinoshita S, Uzu K, Nakano K, Takahashi T. (1971) Mitomycin derivatives. Two. derivatives of decarbamoylmitosane and decarbamoylmitosene, J Med Chem 14:109-12; PMID:4993458; http://dx.doi.org/10.1021/jm00284a006
   PubMed Web of Science ®Google Scholar
• Mendez J, Stillman B. (2000) Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis, Mol Cell Biol 20:8602-12; PMID:11046155; http://dx.doi.org/10.1128/MCB.20.22.8602-8612.2000
   PubMed Web of Science ®Google Scholar